Ausgabe 2/2019
Inhalt (27 Artikel)
Adapting the Goal Attainment Approach for Major Depressive Disorder
Maggie McCue, Sagar V. Parikh, Lisa Mucha, Sara Sarkey, Charlie Cao, Anna Eramo, Mark Opler, Briana Webber-Lind, Clément François
Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?
Victor M. Rivera
Two Sides to Every Story: Perspectives from Four Patients and a Healthcare Professional on Multiple Sclerosis Disease Progression
Jeri Burtchell, Kristen Fetty, Katelyn Miller, Kit Minden, Daniel Kantor
Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
Judith Steinberg, Yara D. Fragoso, Juan Carlos Duran Quiroz, Juan Raul García, Caroline Guerra, Virginia Rodriguez, Claudia Carcamo Rodriguez, Ethel Ciampi, Edgar Correa-Diaz, Miguel Macías, Nelson Novarro, Darwin Vizcarra, Carlos Oehninger Gatti, Geraldine Orozco, Adriana Carrá
Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
Afzal Javed, Holger Arthur, Logos Curtis, Lars Hansen, Sofia Pappa
Fingolimod Immune Effects Beyond Its Sequestration Ability
Francesco Sica, Diego Centonze, Fabio Buttari
Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations
Brian Barry, April A. Erwin, Jessica Stevens, Carlo Tornatore
Cognitive Fatigability Interventions in Neurological Conditions: A Systematic Review
Lisa A. S. Walker, Alyssa P. Lindsay-Brown, Jason A. Berard
Therapy of Sialorrhea with Botulinum Neurotoxin
Wolfgang H. Jost, Tobias Bäumer, Rainer Laskawi, Jaroslaw Slawek, Björn Spittau, Armin Steffen, Martin Winterholler, Ganesh Bavikatte
Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
Amir Abbas Tahami Monfared, Genevieve Meier, Richard Perry, Darren Joe
Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer
Jeremy K. Cutsforth-Gregory, Phillip A. Low
Diagnosing and Treating Depression in Patients with Alzheimer’s Disease
Anna D. Burke, Danielle Goldfarb, Padmaja Bollam, Sehar Khokher
Deep Learning and Neurology: A Systematic Review
Aly Al-Amyn Valliani, Daniel Ranti, Eric Karl Oermann
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)
Annette F. Okai, Lilyana Amezcua, Regina R. Berkovich, Angel R. Chinea, Keith R. Edwards, Brian Steingo, Aljoeson Walker, Alan K. Jacobs, Nadia Daizadeh, Mitzi J. Williams
Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population
Tara Nazareth, Manasi Datar, Tzy-Chyi Yu
Long-Term Observation of the Safety and Effectiveness of Enzyme Replacement Therapy in Japanese Patients with Pompe Disease: Results From the Post-marketing Surveillance
Hitoshi Nagura, Jiro Hokugo, Kazuo Ueda
Effect of Anodal tDCS on Articulatory Accuracy, Word Production, and Syllable Repetition in Subjects with Aphasia: A Crossover, Double-Blinded, Sham-Controlled Trial
Camila Vila-Nova, Pedro H. Lucena, Rita Lucena, Giulia Armani-Franceschi, Fernanda Q. Campbell
Can Generic Intravenous Levetiracetam Be Used for Acute Repetitive Convulsive Seizure or Status Epilepticus? A Randomized Controlled Trial
Rachot Wongjirattikarn, Kittisak Sawanyawisuth, Sineenard Pranboon, Siriporn Tiamkao, Somsak Tiamkao
Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital
Yusuke Nakamura, Isao Shibata, Jörg Mahlich
Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
Tina deVries, Angela Dentiste, Lata Handiwala, David Jacobs
Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials
Angelo Ghezzi, Tanuja Chitnis, Annik K-Laflamme, Rolf Meinert, Dieter A. Häring, Daniela Pohl
Late Onset of Neuromyelitis Optica Spectrum Disorders
Yara Dadalti Fragoso, Heloisa Helena Ruocco, Ronaldo Maciel Dias, Hideraldo Cabeça, Ricardo Gonçalves, Nise A. de Carvalho Sousa, Caroline Vieira Spessotto, Carlos Bernardo Tauil, Soniza Vieira Alves-Leon, Sidney Gomes, Marcus Vinicius M. Gonçalves, Suzana C. Nunes Machado, Andrea Anacleto, Eber Castro Correa, Maria Lucia V. Pimentel, Gutemberg Augusto C. Santos
A Novel Dual-Frequency Deep Brain Stimulation Paradigm for Parkinson’s Disease
Jessica A. Karl, Bichun Ouyang, Leo Verhagen Metman
Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study
Charlotte Lawthom, Pedro Bermejo, Dulce Campos, Rob McMurray, Vicente Villanueva
Case Report of a Novel Technique for Repair of the Vertebral Artery During Cranial Surgery
Manjunath Prasad, Nitin Mukerji
Correction to: Abstracts from the 5th International Porto Congress of Multiple Sclerosis
Maria José Sá
Acknowledgement to Authors, Referees and Readers 2019
Marwan Sabbagh, Antonio Bertolotto